Skip to main content
. 2022 Jun 22;12:10603. doi: 10.1038/s41598-022-14795-6

Table 4.

Distribution of genotypes and alleles of the g.117803515 C > T—NOS1 (rs1879417), c.1823 C > T (p.Ser608Leu)—NOS2 (rs2297518), c.47 C > T—SOD2 (rs4880), c.-89 A > T—CAT (rs7943316), c.660 T > C—GPX4 (rs713041) and Ors with 95% Cis in men and women with MS.

Genotype/allele Men (n = 118) Women (n = 164)
Control (n = 51) MS (n = 67) Crude OR (95% CI)* p Control (n = 89) MS (n = 75) Crude OR (95% CI)* p
N (freq.) N (freq.) N (freq.) N (freq.)
c.-420-34221G > ANOS1 (rs1879417)
G/G 6 (0.118) 14 (0.209) 1.981 (0.703–5.580) 0.196 17 (0.191) 21 (0.280) 1.647 (0.793–3.419) 0.181
G/A 27 (0.529) 37 (0.552) 1.096 (0.528–2.277) 0.805 51 (0.573) 33 (0.440) 0.585 (0.315–1.088) 0.090
A/A 18 (0.353) 16 (0.239) 0.575 (0.258–1.284) 0.177 21 (0.236) 21 (0.280) 1.259 (0.624–2.542) 0.520
χ2 = 2.786; p = 0.095 χ2 = 0.169; p = 0.681
G 39 (0.382) 65 (0.485) 1.605 (0.913–2.819) 0.100 85 (0.478) 75 (0.500) 1.097 (0.706–1.704) 0.681
A 63 (0.618) 69 (0.515) 0.623 (0.355–1.095) 0.100 93 (0.522) 75 (0.500) 0.912 (0.587–1.417) 0.681
c.1823C > T (p.Ser608Leu)NOS2 (rs2297518)
C/C 18 (0.353) 48 (0.716) 4.632 (2.118–10.127) < 0.0010.978 42 (0.472) 51 (0.680) 2.378 (1.255–4.506) 0.0080.767
C/T 18 (0.353) 14 (0.209) 0.484 (0.213–1.102) 0.084 30 (0.337) 15 (0.200) 0.402 (0.240–1.007) 0.052
T/T 15 (0.294) 5 (0.075) 0.194 (0.065–0.577) 0.0030.855 17 (0.191) 9 (0.120) 0.578 (0.241–1.384) 0.218
χ2 = 17.534; p < 0.001 χ2 = 5.804; p = 0.016
C 54 (0.529) 110 (0.821) 2.958 (1.716–5.100)  < 0.0010.774 114 (0.640) 117 (0.780) 1.683 (1.090–2.598) 0.0190.326
T 48 (0.471) 24 (0.179) 0.338 (0.196–0.583) < 0.0010.774 64 (0.360) 33 (0.220) 0.594 (0.385–0.917) 0.0190.327
c.47C > T (p.Val16Ala)SOD2 (rs4880)
C/C 16 (0.314) 15 (0.224) 0.631 (0.277–1.439) 0.274 22 (0.247) 8 (0.107) 0.364 (0.151–0.840) 0.0240.640
T/C 27 (0.529) 41 (0.612) 1.402 (0.671–2.930) 0.369 47 (0.528) 42 (0.560) 1.137 (0.613–2.109) 0.683
T/T 8 (0.157) 11 (0.164) 1.056 (0.391–2.852) 0.915 20 (0.225) 25 (0.333) 1.725 (0.864–3.444) 0.122
χ2 = 0.663; p = 0.415 χ2 = 5.707; p = 0.017
C 59 (0.578) 71 (0.530) 0.790 (0.446–1.397) 0.417 91 (0.511) 58 (0.387) 0.565 (0.350–0.911) 0.0190.434
T 43 (0.422) 63 (0.470) 1.267 (0.716–2.242) 0.417 87 (0.489) 92 (0.613) 1.769 (1.097–2.853) 0.0190.434
c.-89 A > TCAT (rs7943316)
A/A 7 (0.137) 6 (0.090) 0.618 (0.194–1.967) 0.415 17 (0.191) 7 (0.093) 0.436 (0.170–1.117) 0.084
A/T 34 (0.667) 56 (0.836) 2.545 (1.066–6.075) 0.0350.553 63 (0.708) 62 (0.827) 1.968 (0.927–4.177) 0.078
T/T 10 (0.196) 5 (0.075) 0.331 (0.105–1.038) 0.058 9 (0.101) 6 (0.080) 0.773 (0.262–2.281) 0.641
χ2 = 0.667; p = 0.414 χ2 = 1.021; p = 0.312
A 48 (0.471) 68 (0.507) 1.368 (0.642–2.916) 0.417 97 (0.545) 76 (0.507) 0.719 (0.378–1.369) 0.316
T 54 (0.529) 66 (0.493) 0.713 (0.343–1.558) 0.417 81 (0.455) 74 (0.493) 1.390 (0.731–2.644) 0.316
c.660 T > CGPX4 (rs713041)
C/C 23 (0.451) 17 (0.254) 0.414 (0.190–0.902) 0.0260.605 34 (0.382) 22 (0.293) 0.671 (0.349–1.294) 0.234
T/C 21 (0.412) 33 (0.493) 1.387 (0.665–2.892) 0.384 44 (0.494) 39 (0.520) 1.108 (0.599–2.049) 0.744
T/T 7 (0.137) 17 (0.254) 2.137 (0.811–5.632) 0.124 11 (0.124) 14 (0.187) 1.627 (0.690–3.837) 0.266
χ2 = 5.548; p = 0.019 χ2 = 2.052; p = 0.152
C 67 (0.657) 67 (0.500) 0.537 (0.316–0.913) 0.0220.375 112 (0.629) 83 (0.553) 0.716 (0.453–1.134) 0.155
T 35 (0.343) 67 (0.500) 1.862 (1.095–3.167) 0.0220.375 66 (0.371) 67 (0.447) 1.396 (0.882–2.209) 0.155

p < 0.05 along with corresponding ORs are bold and in bold (for the genotypes/alleles contributing to the MS development) or in italics (for the genotypes/alleles with a protective effect); *OR adjusted for gender. Statistical power (1 − β) for significant comparisons is given in superscripts.